Stockscreener 앱 받기
4.53
4.23%
-0.20
Scynexis Inc 주식(SCYX)의 최신 뉴스
Scynexis Deadline Alert - TMX Newsfile
Enterprise value to EBIT forward of SCYNEXIS, Inc. – FWB:135 - TradingView
Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
SCYNEXIS (NASDAQ:SCYX) Is In A Strong Position To Grow Its Business - Sahm
Form DEF 14A Scynexis Inc For: 2 July By Investing.com - Investing.com Canada
Scynexis: Buy Rating Reiterated as Rare Disease Pipeline Advances; $32 Price Target Maintained - TipRanks
Form 4 Scynexis Inc For: 30 June By Investing.com - Investing.com Nigeria
SCYNEXIS (SCYX) director receives new RSU and stock option grants - Stock Titan
SCYNEXIS (NASDAQ: SCYX) director gets RSU and option awards - Stock Titan
SCYNEXIS (SCYX) director Armando Anido granted stock units and options - Stock Titan
SCYNEXIS (SCYX) director receives new stock and option awards - Stock Titan
SCYNEXIS (SCYX) director Ann Hanham receives stock and option grants - Stock Titan
Enterprise value to revenue forward of SCYNEXIS, Inc. – FWB:135 - TradingView
Scynexis (SCYX) Launches Phase 1 Study for SCY-770 in Kidney Dis - GuruFocus
SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) - The Manila Times
Enterprise value to revenue forward of SCYNEXIS, Inc. – NASDAQ:SCYX - TradingView
Enterprise value to revenue forward of SCYNEXIS, Inc. – GETTEX:135 - TradingView
Price to book forward of SCYNEXIS, Inc. – NASDAQ:SCYX - TradingView
Price to earnings forward of SCYNEXIS, Inc. – GETTEX:135 - TradingView
Price to sales forward of SCYNEXIS, Inc. – NASDAQ:SCYX - TradingView
Price to book forward of SCYNEXIS, Inc. – GETTEX:135 - TradingView
Enterprise value to EBITDA forward of SCYNEXIS, Inc. – NASDAQ:SCYX - TradingView
Price to sales forward of SCYNEXIS, Inc. – GETTEX:135 - TradingView
Enterprise value to EBITDA forward of SCYNEXIS, Inc. – GETTEX:135 - TradingView
SCYNEXIS Shareholders Approve Governance and Equity Plan Changes - TipRanks
SCYNEXIS (SCYX) expands authorized stock and registers 87M shares for resale - Stock Titan
SCYNEXIS Inc (SCYX) Valuation: PE, PB & Fair Value Analysis - TradingKey
SCYNEXIS Inc (SCYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
SCYNEXIS Inc (SCYX) Institutional Confidence - TradingKey
SCYNEXIS Inc (SCYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SCYNEXIS Inc (SCYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
SCYNEXIS Inc (SCYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SCYNEXIS Inc (SCYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SCYNEXIS Inc (SCYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
SCYNEXIS Inc (SCYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SCYNEXIS (SCYX) Holds Near Support Amid Quiet TradingFast Moving Stocks - newsline.com
SCYNEXIS Q1 2026 Earnings: EPS Misses Estimates as Company Reports No RevenueInvestor Earnings Call - newsline.com
SCYNEXIS, Inc. Hits New 52-Week High of $5.62, Up 157.49% - MarketsMojo
SCYNEXIS (SCYX) Picks Up Slightly as Stock Bounces Within Established RangeDiagonal Spread Trade - newsline.com
SCYNEXIS (SCYX) Slides 2.6% as Stock Approaches Key SupportATR Trailing Stop - newsline.com
Total liabilities of SCYNEXIS, Inc. – MUN:135 - TradingView
SCYNEXIS, Inc. Balance Sheet – MUN:135 - TradingView
Net debt of SCYNEXIS, Inc. – FWB:135 - TradingView
Pretax income of SCYNEXIS, Inc. – TRADEGATE:135 - TradingView
Free cash flow of SCYNEXIS, Inc. – FWB:135 - TradingView
SCYNEXIS, Inc. Cash Flow – MUN:135 - TradingView
SCYNEXIS, Inc. Cash Flow – FWB:135 - TradingView
Pretax income of SCYNEXIS, Inc. – GETTEX:135 - TradingView
Working capital per share of SCYNEXIS, Inc. – TRADEGATE:135 - TradingView
SCYNEXIS, Inc. Statistics – TRADEGATE:135 - TradingView
Net margin % of SCYNEXIS, Inc. – MUN:135 - TradingView
Net income of SCYNEXIS, Inc. – TRADEGATE:135 - TradingView
SCYNEXIS Inc (FRA:135) Stock Earnings Transcripts - GuruFocus
SCYNEXIS Inc (FRA:135) Stock Price & 30 Year Financial Data - GuruFocus
SCYNEXIS Inc (STU:135) Stock Price & 30 Year Financial Data - GuruFocus
Scynexis Shareholder Alert - TMX Newsfile
SCYNEXIS Inc. (SCYX) Declines 4.12%: Stock Approaches Key Support at $0.66Put Call Ratio - newsline.com
SCYNEXIS to implement 1-for-8 reverse stock split - MSN
Scynexis (SCYX) completes 1-for-8 reverse split and cuts authorized shares - Stock Titan
SCYX Q1 2026 Earnings: EPS Misses Estimates as No Revenue Reported, Stock Rises 4.91%Share Repurchase Impact - The Legal Advocate
SCYNEXIS (SCYX) Shows Modest Uptick, Testing Key Resistance LevelsVolatility Skew - dars.gov.et
SCYNEXIS (SCYX) Falls 6.88%: Key Support and Resistance Levels Under ScrutinyNews Sentiment - The Legal Advocate
SCYXScynexis Inc Stock Price and Quote - Finviz
Stock Market Today: S&P 500, Dow, Nasdaq Futures Up Amid US 'Defensive Strikes' On Iran— Elbit Systems, Intuitive Machines, Zscaler In Focus (UPDATED) - Benzinga
SCYX Q1 2026 Earnings: EPS Misses Estimates; Stock Rises Despite Wider-Than-Expected LossFinancial Data - The Legal Advocate
SCYNEXIS Announces One-for-Eight Reverse Stock Split - The Manila Times
SCYNEXIS (SCYX) Announces 1-for-8 Reverse Stock Split to Meet Na - GuruFocus
SCYNEXIS announces 1-for-8 reverse stock split effective May 29 - Investing.com UK
0.71%
2.30%
자본화:
|
볼륨(24시간):